Cargando…

High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor

BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on...

Descripción completa

Detalles Bibliográficos
Autores principales: Joeckel, Elke, Haber, Tobias, Prawitt, Dirk, Junker, Kerstin, Hampel, Christian, Thüroff, Joachim W, Roos, Frederik C, Brenner, Walburgis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945739/
https://www.ncbi.nlm.nih.gov/pubmed/24576174
http://dx.doi.org/10.1186/1476-4598-13-42
_version_ 1782306566005850112
author Joeckel, Elke
Haber, Tobias
Prawitt, Dirk
Junker, Kerstin
Hampel, Christian
Thüroff, Joachim W
Roos, Frederik C
Brenner, Walburgis
author_facet Joeckel, Elke
Haber, Tobias
Prawitt, Dirk
Junker, Kerstin
Hampel, Christian
Thüroff, Joachim W
Roos, Frederik C
Brenner, Walburgis
author_sort Joeckel, Elke
collection PubMed
description BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on mechanisms of bone metastasis via the calcium-sensing receptor (CaSR) and its downstream signaling molecules. METHODS: Our analyses were performed using 33 (11/category) matched specimens of normal and tumor tissue and 9 (3/category) primary cells derived from RCC patients of the 3 categories: non-metastasized, metastasized into the lung and metastasized into bones during a five-year period after nephrectomy. Expression of CaSR was determined by RT-PCR, Western blot analyses and flow cytometry, respectively. Cells were treated by calcium and the CaSR inhibitor NPS 2143. Cell migration was measured in a Boyden chamber with calcium (10 μM) as chemotaxin and proliferation by BrdU incorporation. The activity of intracellular signaling mediators was quantified by a phospho-kinase array and Western blot. RESULTS: The expression of CaSR was highest in specimens and cells of patients with bone metastases. Calcium treatment induced an increased migration (19-fold) and proliferation (2.3-fold) exclusively in RCC cells from patients with bone metastases. The CaSR inhibitor NPS 2143 elucidated the role of CaSR on the calcium-dependent effects. After treatment with calcium, the activity of AKT, PLCγ-1, p38α and JNK was clearly enhanced and PTEN expression was almost completely abolished in bone metastasizing RCC cells. CONCLUSIONS: Our results indicate a promoting effect of extracellular calcium on cell migration and proliferation of bone metastasizing RCC cells via highly expressed CaSR and its downstream signaling pathways. Consequently, CaSR may be regarded as a new prognostic marker predicting RCC bone metastasis.
format Online
Article
Text
id pubmed-3945739
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39457392014-03-08 High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor Joeckel, Elke Haber, Tobias Prawitt, Dirk Junker, Kerstin Hampel, Christian Thüroff, Joachim W Roos, Frederik C Brenner, Walburgis Mol Cancer Research BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on mechanisms of bone metastasis via the calcium-sensing receptor (CaSR) and its downstream signaling molecules. METHODS: Our analyses were performed using 33 (11/category) matched specimens of normal and tumor tissue and 9 (3/category) primary cells derived from RCC patients of the 3 categories: non-metastasized, metastasized into the lung and metastasized into bones during a five-year period after nephrectomy. Expression of CaSR was determined by RT-PCR, Western blot analyses and flow cytometry, respectively. Cells were treated by calcium and the CaSR inhibitor NPS 2143. Cell migration was measured in a Boyden chamber with calcium (10 μM) as chemotaxin and proliferation by BrdU incorporation. The activity of intracellular signaling mediators was quantified by a phospho-kinase array and Western blot. RESULTS: The expression of CaSR was highest in specimens and cells of patients with bone metastases. Calcium treatment induced an increased migration (19-fold) and proliferation (2.3-fold) exclusively in RCC cells from patients with bone metastases. The CaSR inhibitor NPS 2143 elucidated the role of CaSR on the calcium-dependent effects. After treatment with calcium, the activity of AKT, PLCγ-1, p38α and JNK was clearly enhanced and PTEN expression was almost completely abolished in bone metastasizing RCC cells. CONCLUSIONS: Our results indicate a promoting effect of extracellular calcium on cell migration and proliferation of bone metastasizing RCC cells via highly expressed CaSR and its downstream signaling pathways. Consequently, CaSR may be regarded as a new prognostic marker predicting RCC bone metastasis. BioMed Central 2014-02-28 /pmc/articles/PMC3945739/ /pubmed/24576174 http://dx.doi.org/10.1186/1476-4598-13-42 Text en Copyright © 2014 Joeckel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Joeckel, Elke
Haber, Tobias
Prawitt, Dirk
Junker, Kerstin
Hampel, Christian
Thüroff, Joachim W
Roos, Frederik C
Brenner, Walburgis
High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title_full High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title_fullStr High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title_full_unstemmed High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title_short High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
title_sort high calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945739/
https://www.ncbi.nlm.nih.gov/pubmed/24576174
http://dx.doi.org/10.1186/1476-4598-13-42
work_keys_str_mv AT joeckelelke highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT habertobias highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT prawittdirk highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT junkerkerstin highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT hampelchristian highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT thuroffjoachimw highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT roosfrederikc highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor
AT brennerwalburgis highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor